Arcus Biosciences, Inc.: cash_and_equivalents

Value{"amount": 238000000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2023-03-31)
Statuscurrent
EntityArcus Biosciences, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-019695 · Open the official SEC filing →
Retrieved: 2026-08-19T17:38:25.694721+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001724521/cash-and-equivalents/2023-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/26caccb3-cff0-4c56-a5cc-9709c86ecffb

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies